Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950170-25-045728
Filing Date
2025-03-27
Accepted
2025-03-27 07:23:03
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-1/A apvo-2025-s1a2_-_march_o.htm S-1/A 986185
2 EX-4.13 apvo-ex4_13.htm EX-4.13 215782
3 EX-5.1 apvo-ex5_1.htm EX-5.1 34263
4 EX-23.1 apvo-ex23_1.htm EX-23.1 3772
5 EX-FILING FEES apvo-exfiling_fees.htm EX-FILING FEES 112227
6 GRAPHIC img57496738_0.jpg GRAPHIC 12962
7 GRAPHIC img181513688_0.jpg GRAPHIC 6733
8 GRAPHIC img181513688_1.jpg GRAPHIC 199177
9 GRAPHIC img181513688_2.jpg GRAPHIC 250435
10 GRAPHIC img181513688_3.jpg GRAPHIC 14823
  Complete submission text file 0000950170-25-045728.txt   2020485
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-285476 | Film No.: 25775278
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)